When Ron Muhlenbruck was diagnosed with a rare cancer in 2005, he came to the University of Iowa — then a rising leader in neuroendocrine tumor research. Twenty years later, Iowa remains the only U.S. institution to receive specialized federal funding twice for this rare cancer.